Anahita Rabiee, MD, MHS
Assistant Professor of Medicine (Digestive Diseases)Cards
About
Research
Publications
Featured Publications
Safety of naltrexone in patients with cirrhosis
Thompson R, Taddei T, Kaplan D, Rabiee A. Safety of naltrexone in patients with cirrhosis. JHEP Reports 2024, 6: 101095. PMID: 38961852, PMCID: PMC11220533, DOI: 10.1016/j.jhepr.2024.101095.Peer-Reviewed Original ResearchDrug-induced liver injuryRoussel Uclaf Causality Assessment MethodAlcohol use disorderInitiation of naltrexoneSafety of naltrexoneUse disorderRetrospective studyDevelopment of drug-induced liver injuryRoussel Uclaf Causality Assessment Method scoreLiver injuryLiver diseaseRetrospective study of patientsTreatment of alcohol use disordersTreat alcohol use disorderLiver enzyme elevationAlcohol-related cirrhosisCohort of patientsAlkaline phosphatase elevationDiagnosis of cirrhosisStudy of patientsAssociated with developmentCausality Assessment MethodPrescribed naltrexoneDecompensated cirrhosisEnzyme elevationMedications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis
Rabiee A, Mahmud N, Falker C, Garcia-Tsao G, Taddei T, Kaplan D. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis. Hepatology Communications 2023, 7: e0093. PMID: 36972386, PMCID: PMC10043587, DOI: 10.1097/hc9.0000000000000093.Peer-Reviewed Original ResearchConceptsAlcohol-associated cirrhosisAlcohol use disorderUse disordersCause mortalityImproved survivalPropensity scoreInpatient diagnosis codesRetrospective cohort studyCox regression analysisActive alcohol useCirrhosis decompensationCohort studyConcurrent diagnosisLiver diseasePotential confoundersDiagnosis codesVeteran outcomesCirrhosis diagnosisStrong negative predictorCirrhosisPatientsHazardous drinkingAlcohol use behaviorsCosts AssociatedAlcohol useNoninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model
Rabiee A, Deng Y, Ciarleglio M, Chan JL, Pons M, Genesca J, Garcia‐Tsao G. Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model. Hepatology Communications 2022, 6: 3324-3334. PMID: 36214066, PMCID: PMC9701481, DOI: 10.1002/hep4.2091.Peer-Reviewed Original ResearchConceptsHepatic venous pressure gradientSignificant portal hypertensionTransient elastographyNASH cirrhosisPortal hypertensionFibrosis-4 indexPresence of CSPHVenous pressure gradientNonalcoholic steatohepatitis cirrhosisBody mass indexLiver stiffness measurementGood calibrationCompensated cirrhosisFIB-4Mass indexPlatelet countValidation cohortNoninvasive predictorTraining cohortBaseline riskLaboratory valuesCirrhosisHigh riskSeparate cohortNoninvasive surrogate
2025
Unusual Complication of Percutaneous Gastrostomy Tube Replacement
Liang S, Ketwaroo G, Njei B, Ogurick A, Rabiee A, Protiva P. Unusual Complication of Percutaneous Gastrostomy Tube Replacement. ACG Case Reports Journal 2025, 12: e01834. PMID: 40970177, PMCID: PMC12443151, DOI: 10.14309/crj.0000000000001834.Peer-Reviewed Original ResearchLong-term nutritional supportPercutaneous endoscopic gastrostomy tube insertionGastric outlet obstructionComplete gastric outlet obstructionGastrostomy tube insertionPercutaneous endoscopic gastrostomy tubeOutlet obstructionEsophageal cancerNutritional supportTube insertionGastrostomy tubeCritical illnessNeurological conditionsPrognostic significance of mild ascites in patients with cirrhosis.
Chong Lugon N, Rabiee A, Mezzacappa C, Kaplan D, Taddei T, Garcia-Tsao G. Prognostic significance of mild ascites in patients with cirrhosis. Hepatology 2025 PMID: 40607762, DOI: 10.1097/hep.0000000000001452.Peer-Reviewed Original ResearchMild ascitesMultivariate Cox proportional hazards analysisMedian follow-up timeGrade 1Associated with poor survivalCox proportional hazards analysisKaplan-Meier methodRetrospective cohort studyDiagnosis of cirrhosisProportional hazards analysisGrade of ascitesHigher hazard of mortalityOvert ascitesGrade 2/3Median survivalHazard of mortalityPrognostic significancePrognostic stageDecompensated cirrhosisImaging ReportingDecompensation eventsPoor survivalCohort studyAscitesCirrhosis
2024
Risk of bleeding after percutaneous liver procedures in patients with cirrhosis: Myth or fact?
Rabiee A, Rabiee A. Risk of bleeding after percutaneous liver procedures in patients with cirrhosis: Myth or fact? Liver Transplantation 2024, 31: 259-261. PMID: 39526889, DOI: 10.1097/lvt.0000000000000537.Peer-Reviewed Original ResearchS3535 Unusual Complication of Percutaneous Gastrostomy Tube Replacement
Liang S, Ketwaroo G, Njei B, Ogurick A, Rabiee A, Protiva P. S3535 Unusual Complication of Percutaneous Gastrostomy Tube Replacement. The American Journal Of Gastroenterology 2024, 119: s2341-s2341. DOI: 10.14309/01.ajg.0001043508.94655.75.Peer-Reviewed Original ResearchMo1525 HIGH PREVALENCE OF BARIATRIC SURGERY AMONG PATIENTS PRESENTING WITH ALCOHOL-ASSOCIATED HEPATITIS
Thompson R, Narayanan P, Mistry P, Taddei T, Rabiee A. Mo1525 HIGH PREVALENCE OF BARIATRIC SURGERY AMONG PATIENTS PRESENTING WITH ALCOHOL-ASSOCIATED HEPATITIS. Gastroenterology 2024, 166: s-1679. DOI: 10.1016/s0016-5085(24)04319-1.Peer-Reviewed Original ResearchKeep beta-blocking and carry on!
Rabiee A, Rabiee A. Keep beta-blocking and carry on! Clinical Liver Disease 2024, 23: e0114. PMID: 38304323, PMCID: PMC10833629, DOI: 10.1097/cld.0000000000000114.Peer-Reviewed Original Research
2023
Interventional Radiology and Surgical Treatment Options for Non-Cirrhotic Portal Hypertension
Rabiee A, Cornman-Homonoff J, Kunstman J, Garcia-Tsao G, Taddei T. Interventional Radiology and Surgical Treatment Options for Non-Cirrhotic Portal Hypertension. Current Hepatology Reports 2023, 22: 269-275. DOI: 10.1007/s11901-023-00617-4.Peer-Reviewed Original ResearchPortal hypertensionInterventional radiologyNon-cirrhotic portal hypertensionPorto-sinusoidal vascular diseaseHepatic sinusoidal obstruction syndromeAbsence of cirrhosisPortal vein thrombosisSinusoidal obstruction syndromeBudd-Chiari syndromeSurgical treatment optionsHepatic vascular anatomyObstruction syndromeVein thrombosisSurgical treatmentTreatment optionsVascular diseaseImproved outcomesTherapeutic evaluationVascular anatomyHeterogenous groupHypertensionSyndromeDisordersOutcomesTreatment
Academic Achievements & Community Involvement
Clinical Care
Overview
Clinical Specialties
Gastroenterology; Hepatology; Transplant Hepatology
Board Certifications
Gastroenterology
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2022
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2019
News
News
- October 02, 2025Source: Everyday Health
Metabolic-Associated Steatohepatitis (MASH) Treatment
- August 02, 2023
Highlighting Gender-based Differences in Alcohol-associated Hepatitis
- January 16, 2023
Yale School of Medicine community stand in solidarity with Iranian healthcare workers in poignant demonstration
- January 11, 2023
Discoveries & Impact (January 2023)
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.